Related Experiment Video
Updated: Dec 2, 2025

07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
27.5K
rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report
Andrea Aira1, Elisa Rubio2,3, Andrea Vergara Gómez4,5
1Department of Infectious Diseases, Hospital Clinic, Barcelona, Spain.
Infectious Diseases and Therapy
|November 2, 2020
Summary
Fecal microbiota transplantation (FMT) successfully treated recurrent Clostridioides difficile infection (CDI) and recurrent urinary tract infections (rUTI) in a patient. FMT restored gut microbiota balance, reducing pathogens linked to UTIs.
Area of Science:
- Microbiology
- Gastroenterology
- Urology
Background:
- Clostridioides difficile infection (CDI) is a major cause of hospital-acquired diarrhea.
- Recurrent urinary tract infections (rUTI) can be linked to gut microbiota dysbiosis.
- Fecal microbiota transplantation (FMT) is effective for recurrent CDI (rCDI) and may impact rUTI.
Purpose of the Study:
- To investigate the potential of FMT in treating co-existing rCDI and rUTI.
- To analyze the impact of FMT on gut microbiota composition in a patient with rCDI and rUTI.
- To explore the link between gut dysbiosis and recurrent infections.
Main Methods:
- Case report of a 93-year-old female patient with rCDI and rUTI.
- Fecal microbiota transplantation (FMT) procedure.
- 16S rRNA gene sequencing to characterize gut microbiota before and after FMT.
- Clinical follow-up for CDI and UTI symptoms.
Main Results:
- Successful clinical resolution of CDI post-FMT.
- Unexpected resolution of rUTI symptoms post-FMT, with no new episodes diagnosed.
- Significant reduction in gut Enterobacteriaceae from 74% to 0.07% post-FMT.
- Increased gut microbial diversity post-FMT, comparable to donor levels.
Conclusions:
- FMT may be a viable therapeutic option for recurrent urinary tract infections (rUTI), especially those caused by multi-drug resistant pathogens.
- Restoration of gut microbiota balance through FMT can lead to the resolution of both CDI and rUTI.
- Gut dysbiosis, particularly Enterobacteriaceae overgrowth, may contribute to recurrent infections in both the gut and urinary tract.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
323
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
323
Drugs for Treatment of Constipation-Predominant IBS
535
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
535
Drugs for Treatment of Diarrhea-Predominant IBS
470
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
470

